Overview of Pathology and Laboratory Features of COVID-19
DOI:
https://doi.org/10.3889/oamjms.2020.5296Keywords:
SARS-CoV2, Coronavirus, Pathology of COVID-19, Diagnosis of COVID-19Abstract
BACKGROUND: The third identified severe respiratory disease in the past two decades and the first to result in a pandemic is the coronavirus disease 2019 (COVID-19) specifically caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
AIM: The aim of this study was to provide an overview of the basic pathology and diagnostic laboratory features of COVID-19.
METHODS: This review involved search of literatures on PubMed, Science alert, Medline, and Advanced Google search using the keywords “SARS-CoV2,” “Coronavirus” along with “pathology of COVID-19” and “diagnosis of COVID-19” with related articles pooled, relevant information extracted, and properly referenced.
RESULTS: The recommended method of diagnosis is by nucleic acid testing of the viral ribonucleic acid in which real-time reverse-transcription polymerase chain reaction followed by nucleic acid sequencing when required is performed while some serologic techniques developed include enzyme-linked immunosorbent assay, immunochromatographic lateral flow assay, neutralization bioassay, and specific chemosensors to detect the immunoglobulin M and immunoglobulin G antibodies produced, although sole use of serologic tests is highly discouraged by monitoring agencies. The hematological features display leukocytosis with lymphocytopenia, eosinopenia, reduced procalcitonin along with increased D-dimer, C-reactive protein, serum amyloid A, fibrin, fibrin degradation products, and some inflammatory markers such as interleukin (IL)-2, IL-6, IL-7, IL-10, granulocyte colony-stimulating factor, MCP10, interferon gamma-induced protein 10, and tumor necrosis factor-α. The pathologic presentations include pleurisy, lung consolidation, pulmonary edema and pericarditis along with other features of acute respiratory syndrome, myocardial injury, and acute kidney injury.
CONCLUSION: There are highly efficacious and reliable methods of diagnosis of COVID-19 which also determine the stage and severity of the condition, and these methods are performed in line with specific clinical presentations. However, more studies are required to identify the capabilities, characteristics, and tendencies of this novel virus.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730-41. https://doi.org/10.1111/all.14238 PMid:32077115
World Health Organization. WHO Director General’s Opening Remarks at the Media Briefing on Coronavirus Disease (COVID-2019). Geneva: World Health Organization; 2020. Available from: https://www.who.int/dg/speeches/detail. [Last accessed on 2020 Mar 11].
Center for Disease Control and Prevention. Novel Coronavirus, Wuhan, China; 2020. Available from: https://www.cdc.gov/coronavirus/2019-nCoV/summary.html. [Last accessed on 2020 Apr 01].
World Health Organization. Coronavirus Disease (COVID-2019) Situation Reports. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situationreports. [Last accessed on 2020 Feb 19].
Fehr AR, Channappanavar R, Perlman S. Middle East respiratory syndrome: Emergence of a pathogenic human coronavirus. Annu Rev Med. 2017;68(1):387-99. https://doi.org/10.1146/annurev-med-051215-031152 PMid:27576010
Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418-23. https://doi.org/10.1002/jmv.25681 PMid:31967327
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/s0140-6736(20)30183-5 PMid:31986264
Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020;92(6):568-76. https://doi.org/10.1002/jmv.25748 PMid:32134116
Guan W, Ni Z, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of 2019 Novel Coronavirus Infection in China. New York: medRxiv; 2020.
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-74. PMid:32007145
Zhou P, Yang XL, Wang, XG, Hu B, Zhang L, Zhang W, et al. Discovery of a Novel Coronavirus Associated with the Recent Pneumonia Outbreak in Humans and its Potential Bat Origin. NewYork: bioRxiv; 2020.
Tan W, Zhao X, Ma X, Wang W, Niu P, Xu W, et al. A novel coronavirus genome identified in a cluster of pneumonia cases-Wuhan, China 2019-2020. China CDC Wkly. 2020;2(4):61-2. https://doi.org/10.46234/ccdcw2020.017
World Health Organization. Emergency Diseases: Novel Corona Virus. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/dashboard. [Last accessed on 2020 Mar 10].
Nigeria Center for Disease Control and Prevention. Factsheets on COVID-19. Available from: https://www.covid19.ncdc.gov.ng. [Last accessed on 2020 Mar 10].
Tang B, Wang X, Li Q, Bragazzi NL, Tang S, Xiao Y, et al. Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions. J Clin Med. 2020;9(2):462. https://doi.org/10.2139/ssrn.3525558 PMid:32046137
Chen J. Pathogenicity and transmissibility of 2019-nCoV-a quick overview and comparison with other emerging viruses. Microbes Infect. 2020;22(2):69-71. https://doi.org/10.1016/j.micinf.2020.01.004
Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020;27(2):taaa021. https://doi.org/10.1093/jtm/taaa021 PMid:32052846.
Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A datadriven analysis in the early phase of the outbreak. Int J Infect Dis. 2020;92:214-7. https://doi.org/10.1101/2020.01.23.916395 PMid:3200764
Atere AD, Oduwole OA, Okpoli HC, Hassan AO. Coronavirus: Resilient nightmare of the COVID-19 pandemic in Africa. J Med Lab Sci. 2020;30(1):90-5.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33. PMid:31978945
Adhikari S, Meng S, Wu Y, Mao YP, Ye RX, Wang QZ, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review. Infect Dis Poverty. 2020;9(1):29. https://doi.org/10.1186/s40249-020-00646-x PMid:32183901
National Health Commission of People’s Republic of China. Prevent Guideline of 2019-nCoV; 2020. Available from: http://www.nhc.gov.cn/xcs/yqfkdt/202001/bc661e49b5bc487dba182f5c49ac445b.shtml. [Last accessed on 2020 Apr 03].
Su S, Wong G, Shi W, Liu J, Lai AC, Zhou J, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trend Microbiol. 2016;24(6):490-502. PMid:27012512
Peiris JS, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nat Med. 2004;10(12 Suppl):S88-97. https://doi.org/10.1038/nm1143 PMid:15577937.
Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814-20. https://doi.org/10.1056/nejmoa1211721 PMid:23075143
Chinese Center for Disease Control and Prevention. Environmental Samples from the South China Seafood Market in Wuhan, Hubei Province, China; 2020. Available from: http://www.chinacdc.cn/yw_9324/202001/t20200127_211469.html. [Last accessed on 2020 Apr 03]. https://doi.org/10.46234/ccdcw2020.022
Lu H, Tang CW, Tang Y. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol. 2020;92(4):401-2. https://doi.org/10.1002/jmv.25678 PMid:31950516
Ahmed T, Noman M, Almatroudi A, Shahid M, Khurshid M, Tariq F, et al. Coronavirus Disease 2019 Assosiated Pneumonia in China: Current Status and Future Prospects. Basel, Switzerland: Preprints Organization, MDPI Company; 2020. https://doi.org/10.20944/preprints202002.0358.v3
Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020;63(3):457-60. https://doi.org/10.1007/s11427-020-1637-5 PMid:32009228
Aditya A, Kendall C, Pamela C, Nicole MG, Pinky L, Blake O, et al. From Bench to Bedside. Student Handbook. 1-35.
Suzuki K, Wada H, Imai H, Iba T, Thachil J, Toh CH, et al. A re-evaluation of the D-dimer cut-off value for making a diagnosis according to the ISTH overt-DIC diagnostic criteria: Communication from the SSC of the ISTH. J Thromb Haemost. 2018;16(7):1442-4. https://doi.org/10.1111/jth.14134 PMid:29846034
Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033-40. https://doi.org/10.1182/blood.2020006000 PMid:32339221
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-8. https://doi.org/10.1016/s0140-6736(20)30937-5 PMid:32325026
Iba T, Levy JH, Thachil J, Wada H, Levi M, Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis. The progression from coagulopathy to disseminated intravascular coagulation in representative underlying diseases. Thromb Res. 2019;179:11-4. https://doi.org/10.1016/j.thromres.2019.04.030 PMid:31059996
Iba T, Levy JH, Wada H, Thachil J, Warkentin TE, Levi M, Subcommittee on Disseminated Intravascular Coagulation. Differential diagnoses for sepsis-induced disseminated intravascular coagulation: Communication from the SSC of the ISTH. J Thromb Haemost. 2019;17(2):415-9. https://doi.org/10.1111/jth.14354 PMid:30618150
Mason RJ. Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J. 2020;55(4):2000607. https://doi.org/10.1183/13993003.00607-2020 PMid:32269085
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-80. https://doi.org/10.1016/j.cell.2020.02.052 PMid:32142651
Sims AC, Baric RS, Yount B, Burkett SE, Collins PL, Pickles RJ. Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: Role of ciliated cells in viral spread in the conducting airways of the lungs. J Virol. 2005;79(24):15511-24. https://doi.org/10.1128/jvi.79.24.15511-15524.2005 PMid:16306622
Kumar PA, Hu Y, Yamamoto Y, Hoe NB, Wei TS, Mu D, et al. Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell. 2011;147(3):525-38. https://doi.org/10.1016/j.cell.2011.10.001 PMid:22036562
Yee M, Domm W, Gelein R, Bentley KL, Kottmann RM, Sime PJ, et al. Alternative progenitor lineages regenerate the adult lung depleted of alveolar epithelial Type 2 cells. Am J Respir Cell Mol Biol. 2017;56(4):453-64. https://doi.org/10.1165/rcmb.2016-0150oc PMid:27967234
Coleman JJ, Manavi K, Marson EJ, Botkai AH, Sapey E. COVID-19: To be or not to be; that is the diagnostic question. Postgrad Med J. 2020;96(1137):392-8. https://doi.org/10.1136/postgradmedj-2020-137979 PMid:32522844
Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382(12):1177-9. https://doi.org/10.1056/nejmc2001737 PMid:32074444
Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382(10):929-36. PMid:32004427
Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970-1. https://doi.org/10.1056/nejmc2001468 PMid:32003551
Chan JF, Yip CC, To KK, Tang TH, Wong SC, Leung KH, et al. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-PCR assay validated in vitro and with clinical specimens. J Clin Microbiol. 2020;58(5):e00310-20. https://doi.org/10.1128/jcm.00310-20 PMid:32132196
Center for Disease and Control and Prevention. Coronavirus 2019-nCoV Laboratory Guidelines for Clinical Specimens. Available from: https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html. [Last accessed on 2020 May 10].
Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843-4. https://doi.org/10.1001/jama.2020.3786 PMid:32159775
Cheng Y, Canuto VM, Howard AM, Ackerman AS, Kelley M, Fridlind AM, et al. A second-order closure turbulence model: New heat flux equations and no critical Richardson number. J Atmos Sci. 2020;77(8):2743-59. https://doi.org/10.1175/jas-d-19-0240.1
Tang A, Tong ZD, Wang HL, Dai YX, Li KF, Liu JN, et al. Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child, China. Emerg Infect Dis. 2020;26(6):1337-9. https://doi.org/10.3201/eid2606.200301 PMid:32150527
Zhang W, Du RH, Li B, Zheng XS, Yang XL, Hu B, et al. Molecular and serological investigation of 2019-nCoV infected patients: Implication of multiple shedding routes. Emerg Microbes Infect. 2020;9(1):386-9. https://doi.org/10.1080/22221751.2020.1729071 PMid:32065057
Mondanizadeh M, Rahimi E, Sarmadian H, Jamalian M, Khansarinejad B. Evaluation of SARS-CoV-2 Existence in Blood, Urine, and Rectal Swab in Positive Patients with Different Virus Titers. United States: Research Square; 2020. https://doi.org/10.21203/rs.3.rs-20499/v1
Carter LJ, Garner LV, Smoot JW, Li Y, Zhou Q, Saveson CJ, et al. Assay techniques and test development for COVID-19 diagnosis. ACS Cent Sci 2020;6(5):591-605. https://doi.org/10.1021/acscentsci.0c00501 PMid:32382657
Wang H, Li X, Li T, Zhang S, Wang L, Wu X, et al. The genetic sequence, origin, and diagnosis of SARS-CoV-2. Eur J Clin Microbiol Infect Dis. 2020;39(9):1629-35. https://doi.org/10.1007/s10096-020-03899-4 PMid:32333222
World Health Organization. Laboratory Biosafety Manual. 3rd ed. Geneva: World Health Organization; 2004.
World Health Organization. Laboratory Testing for 2019 Novel Coronavirus (2019-nCoV) in Suspected Human Cases. Geneva: World Health Organization; 2020.
Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess Cruise Ship, Yokohama, Japan, 2020. Euro Surveill. 2020;25(10):2000180. https://doi.org/10.2807/1560-7917.es.2020.25.10.2000180 PMid:32183930
Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARSCoV-2 infection. J Med Virol. 2020;92(6):589-94. https://doi.org/10.1002/jmv.25725 PMid:32100876
American College of Physicians. COVID-19 Found in Sputum and Feces Samples after Pharyngeal Specimens No Longer Positive. Rockville, MD: Science Daily; 2020.
Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2020;28(12):E63. https://doi.org/10.1093/nar/28.12.e63 PMid:10871386
Hong TC, Mai QL, Cuong DV, Parida M, Minekawa H, Notomi T, et al. Development and evaluation of a novel loop-mediated isothermal amplification method for rapid detection of severe acute respiratory syndrome coronavirus. J Clin Microbiol. 2004;42(5):1956-61. https://doi.org/10.1128/jcm.42.5.1956-1961.2004 PMid:15131154
Seliger H, Rampal JB. Microarrays. In: Methods in Molecular Biology. 2nd ed., Vol. 1. Humana Press; 2017. p. 381.
Guo X, Geng P, Wang Q, Cao B, Liu B. Development of a single nucleotide polymorphism DNA microarray for the detection and genotyping of the SARS coronavirus. J Microbiol Biotechnol. 2014;24(10):1445-54. https://doi.org/10.4014/jmb.1404.04024 PMid:24950883
Hardick J, Metzgar D, Risen L, Myers C, Balansay M, Malcom T, et al. Initial performance evaluation of a spotted array Mobile Analysis Platform (MAP) for the detection of influenza A/B, RSV, and MERS coronavirus. Diagn Microbiol Infect Dis. 2018;91(3):245-7. https://doi.org/10.1016/j.diagmicrobio.2018.02.011 PMid:29550057
Centers for Disease Control and Prevention. Crisis Managemnet Documents for Serologic Testing; 2020. Available from: https://www.aphl.org/programs/preparedness/crisismanagement/documents/Serologic-testingfor-COVID-19.pdf. [Last accessed on 2020 Mar 10].
Food and Drug Administration. Emergency Use Authorisation of Serology Test; 2020. Available from: https://www.fda.gov/media/135659/download. [Last accessed on 2020 Mar 10]
Pan Y, Li X, Yang G, Fan J, Tang Y, Zhao J, et al. Serological immunochromatographic approach in diagnosis with SARSCoV-2 infected COVID-19 patients. J Infect. 2020;81(1):e28-32. https://doi.org/10.1016/j.jinf.2020.03.051 PMid:32283141
Gorse GJ, Donovan MM, Patel GB. Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses. J Med Virol. 2020;92(5):512-7. https://doi.org/10.1002/jmv.25715 PMid:32073157
Fan BE, Chong VC, Chan SS, Lim GH, Lim KG, Tan GB, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020;95(6):E131-4. PMid:32129508
Robin EF, Marcel L, Reecha S, Jeffrey KA. Thrombosis in COVID-19: Clinical Outcomes, Biochemical and Pathological Changes, and Treatments. Centre for Evidence Based Medicine; 2020. Available from: https://www.cebm.net/covid-19/thrombosis-in-covid-19-clinical-outcomes-biochemical-andpathological-changes-and-treatments. [Last accessed on 2020 Mar 10]
Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, et al. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18(7):1738-42. https://doi.org/10.1111/jth.14850 PMid:32302438
Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023-6. https://doi.org/10.1111/jth.14810 PMid:32338827
Zhou S, Wang Y, Zhu T, Xia L. CT features of coronavirus disease 2019 (COVID-19) pneumonia in 62 patients in Wuhan, China. Am J Roentgenol. 2020;214(6):1287-94. https://doi.org/10.2214/ajr.20.22975 PMid:32134681
Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). Treasure Island, FL: StatPearls Publishing; 2020.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirusinfected pneumonia. N Engl J Med. 2020;382:1199-207.
Shen K, Yang Y, Wang T, Zhao D, Jiang Y, Jin R, et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: Experts’ consensus statement. World J Pediatr. 2020;16(3):223-1. PMid:32034659
Ragab D, Eldin HS, Taeimah M, Khattab R, Salem R. The COVID-19 cytokine storm; what we know so far. Front Immunol. 2020;11:1446. https://doi.org/10.3389/fimmu.2020.01446 PMid:32612617
Shimizu M. Clinical features of cytokine storm syndrome. In: Cron R, Behrens E, editors. Cytokine Storm Syndrome. Cham: Springer; 2019. p. 31-42. https://doi.org/10.1007/978-3-030-22094-5_3
Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-8. https://doi.org/10.1007/s00134-020-05991-x PMid:32125452
Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620-9. PMid:32217835
Gao Y, Li T, Han M, Li X, Wu D, Xu Y, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020;92(7):791-6. https://doi.org/10.1002/jmv.25770 PMid:32181911
Chen L, Liu H, Liu W, Liu J, Liu K, Shang J, et al. Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:203-8. PMid:32026671
Sun D, Li H, Lu X, Xiao H, Ren J, Zhang FR, et al. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: A single center’s observational study. World J Pediatr. 2020;16(3):251-9. https://doi.org/10.1007/s12519-020-00354-4 PMid:32193831
Zhou P, Yang XL, Wang XG, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3.
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420-2. https://doi.org/10.1016/s2213-2600(20)30076-x PMid:32085846
Sufang T, Yong X, Huan L, Li N, Jianchun G, Meiyan L, et al. Pathological study of the 2019 novel coronavirus disease (covid-19) through postmortem core biopsies. Mod Pathol. 2020;33:1007-14.
Turner AJ, Hiscox JA, Hooper NM. ACE2: From vasopeptidase to SARS virus receptor. Trends Pharmacol Sci. 2004;25:291-4. https://doi.org/10.1016/j.tips.2004.04.001 PMid:15165741
Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, et al. Genome composition and divergence of the novel coronavirus (2019- nCoV) originating in China. Cell Host Microbe. 2020;27(3):325-8. https://doi.org/10.1016/j.chom.2020.02.001 PMid:32035028
Liu Y, Yang Y, Zhang C. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364-74. https://doi.org/10.1007/s11427-020-1643-8 PMid:32048163
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-60. PMid:32139904
Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: A review. JAMA Cardiol. 2020;5(7):831-40. https://doi.org/10.1001/jamacardio.2020.1286 PMid:32219363
Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75(18):2352-71. https://doi.org/10.1016/j.jacc.2020.03.031 PMid:32201335
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811-8. https://doi.org/10.1001/jamacardio.2020.1017 PMid:32219356
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395(10229):1054-62. https://doi.org/10.1016/s0140-6736(20)30566-3 PMid:32171076
Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020;63(3):390-1. https://doi.org/10.1016/j.pcad.2020.03.001 PMid:32169400
Woelfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Mueller MA, et al. Clinical Presentation and Virological Assessment of Hospitalized Cases of Coronavirus Disease 2019 in a Travel-Associated Transmission Cluster. New York: MedRxiv; 2020. https://doi.org/10.1101/2020.03.05.20030502
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2020 Oluwaseyi Eunice Bamisaye, Funmilayo Ajoke Adewumi, Ayodeji Blessing Ajileye (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
